Table 2

Echocardiography parameters of the study participants according to phenogroups by LCA in the derivation cohort

Younger populationOlder populationP value*
Group 1 (n=517)Group 2 (n=249)Group 3 (n=171)Group 4 (n=461)Group 5 (n=231)
Least comorbiditiesMen with LV enlargementPredominantly women with rheumatic MRLow-risk older patientsHigh-risk older patients
LV end-systolic diameter (mm)37 (34–40)43 (40–47)41 (38–45)34 (32–37)39 (35–44)<0.001
LV end-diastolic diameter (mm)60 (56–63)65 (61–69)61 (56–65)57 (54–60)60 (56–65)<0.001
LV end-systolic volume (mL)57 (47–68)78 (61–93)61 (47–78)46 (37–57)55.5 (40–71)<0.001
LV end-diastolic volume (mL)164 (136–195)193 (162–230)147 (117–185)139 (113–165)135 (110–168)<0.001
LV end-systolic volume index (mL/m2)31.7 (26.5–37.7)41.6 (32.5–50.0)37.8 (29.5–48.4)26.6 (22.0–32.7)34.6 (25.8–44.6)<0.001
LV end-diastolic volume index (mL/m2)91.2 (76.2–109.6)102.1 (86.0–122.6)90.3 (73.5–111.9)81.3 (67.0–97.5)85.2 (70.4–107.5)<0.001
LV ejection fraction (%)65.0 (61.7–68.2)60.2 (54.7–65.0)58.9 (53.0–63.1)66.4 (62.8–70.0)59.8 (54.0–65.1)<0.001
LV mass index (g/m2)124.3 (108.1–142.1)151.6 (133.9–175.4)129.4 (109.5–155.9)127.4 (108.8–146.4)145.6 (122.0–168.2)<0.001
LA dimension (mm)46.0 (42.0–50.0)59.0 (55.0–65.0)59.0 (55.5–64.5)48.0 (44.0–52.0)56.5 (51.0–63.0)<0.001
E-wave (m/s)1.14 (0.98–1.37)1.44 (1.21–1.66)1.60 (1.28–2.06)1.22 (1.00–1.44)1.40 (1.20–1.62)<0.001
e’-wave (cm/s)9.0 (7.4–10.6)7.8 (6.2–9.1)7.2 (6.0–9.0)6.6 (5.6–7.9)6.2 (5.0–7.8)<0.001
E/e’ ratio12.0 (10.0–15.0)16.0 (13.0–22.0)19.0 (14.0–33.0)17.0 (13.0–21.0)20.0 (15.0–29.0)<0.001
TR peak velocity, m/s2.5 (2.3–2.8)3.1 (2.7–3.4)2.9 (2.6–3.3)2.8 (2.5–3.3)3.3 (3.0–3.6)<0.001
  • Values are expressed in median (IQR).

  • *Comparison between five groups.

  • AF, atrial fibrillation; LA, left atrium; LCA, latent class analysis; LV, left ventricular; MR, mitral regurgitation; TR, tricuspid regurgitation.